Act. The Pharmacy and Poisons Board, established under these acts, is responsible for implementing regulations. Begin by familiarizing yourself with the following:

• Legislative Documents: Review the specific laws and guidelines issued by the PPB, such as the Health Act.
• Sectoral Guidelines: PPB provides guidelines on the classification of medical devices and IVDs, which determine the submission requirements.
• Standards and Quality Assurance: Understand ISO 13485 and ISO 14971, as these serve as a basis for quality management across medical device manufacturing.

Documentation and compliance with these laws are essential, as non-compliance could result in delays or denial of market entry. Consult relevant guidelines issued by the World Health Organization (WHO) related to medical device regulation. It’s also beneficial to engage with local professionals and regulatory consultants to navigate these requirements effectively.

Step 2: Classifying Your Medical Device or IVD

Classification of medical devices and IVDs is a pivotal step as it influences the regulatory requirements pertaining to design, testing, and post-market surveillance. Classification in Kenya typically aligns with the Global Harmonization Task Force (GHTF) classification system, which includes Class A (low risk) to Class D (high risk). The following steps assist in accurately classifying your device:

• Determine the Device’s Intended Use: Analyze the purpose of your device. Is it diagnostic, therapeutic, or for monitoring?
• Consult PPB Classification Guidelines: Refer to the PPB’s classification rules to categorize your device based on the risks associated.
• Seek Expert Opinion: If uncertain, acquire the expertise of regulatory consultants or legal advisors experienced in medical device classification.

Correct classification is crucial as it dictates the specific regulations and requirements for submission. For instance, higher-risk devices may necessitate more extensive clinical data and a more lengthy approval process, while lower-risk devices may require only basic documentation.

Step 3: Preparing the Dossier for Submission

Once the device has been classified, the next essential step is the preparation of the submission dossier. A well-structured dossier is critical for regulatory approval. The content typically encompasses:

• Device Description: An detailed account of the device’s purpose, design, materials used, and any specific technology involved.
• Clinical Evaluation Report: This includes data from preclinical/performance evaluations and clinical trials, if applicable, demonstrating the device’s safety and efficacy.
• Quality Management System (QMS) Documentation: Provide proof of compliance with ISO 13485 for quality management, including the documentation of procedures, policies, and associated records.
• Risk Management Documentation: Prepare a risk analysis report in accordance with ISO 14971, illustrating how potential hazards have been identified and mitigated.

Beyond these basic components, regulatory teams must also prepare specific forms required by the PPB, which may include declaration forms and any additional certificates pertinent to the device such as CE marks for European devices. Ensure all documentation is clear, precise, and complies with PPB guidelines to facilitate the review process.

Step 4: Submission of the Dossier to the PPB

Upon compiling all necessary documentation, the next step is submitting the dossier to the Pharmacy and Poisons Board. The submission process entails several critical actions:

• Submission Channel: The PPB accepts dossiers through its official platform. Verify the desired submission method, as electronic submissions are increasingly common.
• Submission Fee: Payment of the applicable fee is required upon submission. Access the PPB website for the latest fee schedules for device types.
• Confirmation of Receipt: After submission, ensure to obtain a confirmation receipt from the PPB as proof of submission.

It is advisable to retain copies of all submitted documents as they might be requested during the review process or for compliance purposes later. Regulatory teams should also prepare to respond promptly to any requests for additional information or clarification from the PPB during the review phase.

Step 5: Review Process by the PPB

Upon submission, the PPB conducts a thorough review of the dossier adhering to established timelines. The review phases typically involve:

• Technical Review: This phase includes evaluating the clinical data, risk management, and conformity with QMS regulations. Technical evaluators will assess the adequacy and appropriateness of the documentation provided.
• Scheduling Audits: Depending on the classification of the device, the PPB might conduct facility audits to ensure compliance with manufacturing standards and QMS requirements.
• Approval or Rejection Notification: After the review, the PPB will issue a notification regarding the approval, conditional approval, or rejection of the application. Reasons for any rejection will be provided to facilitate corrective action.

During this period, it’s critical for the regulatory affairs team to remain engaged, providing any requested information promptly and keeping thorough records of all communications with the PPB. The health of the review process may depend on timely responses.

Step 6: Post-Approval Commitments and Market Surveillance

Once a device has received regulatory approval, ongoing compliance with post-approval commitments is vital. These obligations may include:

• Post-Market Surveillance: Develop a robust post-market surveillance plan to gather data on the device’s performance and safety in real-world settings. This may include registries or patient follow-ups.
• Adverse Event Reporting: Establish a system for reporting and managing adverse events associated with the device. Compliance with pharmacovigilance requirements is essential and should adhere to guidelines set forth by the PPB.
• Periodic Safety Reports: Depending on the device classification, routine reports may be required to update the PPB on the safety and performance of the device.

Regulatory teams must familiarize themselves with the timeline for any post-approval reports and the associated submission formats outlined by the PPB. It is also crucial to stay updated on evolving regulations and standards that may affect existing products in the market.

Step 7: Maintaining Compliance and Addressing Regulatory Updates

The regulatory environment is dynamic; thus, maintaining compliance with evolving regulations is critical for manufacturers of medical devices and IVDs. Actions to consider include:

• Continuous Education: Regularly attend training sessions, webinars, and workshops focused on regulatory affairs in the pharmaceutical industry to stay informed about new developments.
• Engaging with Regulatory Authorities: Maintain ongoing dialogue with the PPB and other relevant authorities to ensure alignment with current practices and expectations.
• Internal Audits: Conduct periodic internal audits to review compliance with regulatory requirements and identify areas for improvement.

Building a proactive compliance culture within your organization can safeguard against potential issues and enhance the overall quality of the devices being brought to market. As the market evolves, adjustments to regulatory strategies may be necessary to address any new challenges posed by innovations or changes in legislation.